Rallybio (RLYB) Stock Forecast & Price Target

$0.91 -0.04 (-4.22%)

(As of 02:57 PM ET)

Rallybio - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
2

Buy
4

Based on 6 Wall Street analysts who have issued ratings for Rallybio in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 2 have given a hold rating, and 4 have given a buy rating for RLYB.

Consensus Price Target

$9.75
971.55% Upside

According to the 6 analysts' twelve-month price targets for Rallybio, the average price target is $9.75. The highest price target for RLYB is $15.00, while the lowest price target for RLYB is $5.00. The average price target represents a forecasted upside of 971.55% from the current price of $0.91.

Get the Latest News and Ratings for RLYB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Rallybio and its competitors.

RLYB Analyst Ratings Over Time

Type	Current Forecast 12/24/23 to 12/23/24	1 Month Ago 11/24/23 to 11/23/24	3 Months Ago 9/25/23 to 9/24/24	1 Year Ago 12/24/22 to 12/24/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$9.75	$9.75	$10.00	$16.00
Forecasted Upside	971.55% Upside	855.88% Upside	809.09% Upside	506.06% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

RLYB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RLYB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Rallybio Stock vs. The Competition

Type	Rallybio	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	926.32% Upside	25,827.31% Upside	14.53% Upside
News Sentiment Rating	Neutral News See Recent RLYB News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
12/3/2024	HC Wainwright 2 of 5 stars	Reiterated Rating	Buy ➝ Buy	$5.00 ➝ $5.00	+342.47%
8/26/2024	Evercore ISI 2 of 5 stars	Reiterated Rating	Outperform ➝ Outperform	$15.00 ➝ $15.00	+1,215.78%
5/15/2024	JPMorgan Chase & Co. 3 of 5 stars	Downgrade	Overweight ➝ Neutral
4/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$8.00	+359.77%
4/11/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$13.00 ➝ $11.00	+305.92%
2/7/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:29 PM ET.

RLYB Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Rallybio is $9.75, with a high forecast of $15.00 and a low forecast of $5.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rallybio in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RLYB shares.
: According to analysts, Rallybio's stock has a predicted upside of 971.55% based on their 12-month stock forecasts.
: Rallybio has been rated by research analysts at HC Wainwright in the past 90 days.
: Analysts like Rallybio less than other "medical" companies. The consensus rating score for Rallybio is 2.67 while the average consensus rating score for "medical" companies is 2.81. Learn more on how RLYB compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Mysterious drone activity triggers massive 1,366% surge (Ad)

If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.

👉 Click here now to see how this signal works.

This page (NASDAQ:RLYB) was last updated on 12/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rallybio (RLYB) Stock Forecast & Price Target